58 research outputs found

    Management of perioperative bleeding risk in patients on antithrombotic medications undergoing cardiac surgery—a systematic review

    Get PDF
    Background: Antithrombotic drugs increase the risk of bleeding, especially in patients who need urgent surgery without an adequate wash-out period. This review aims to evaluate perioperative bleeding complications in patients on dual antiplatelet therapy (DAPT) or direct-acting oral anticoagulants (DOACs) undergoing high-bleeding risk cardiovascular surgery and to present currently available potential solutions to mitigate antithrombotic therapy-related bleeding complications. Methods: As a first step, we searched for relevant articles, over the last 10 years, in Medline (PubMed) and abstracted clinical information based on pre-defined criteria for bleeding complications. In the next step, an additional search evaluating potential solutions to mitigate bleeding complications was performed. The literature screening and selection process followed the principles derived from the PRISMA statement. Results: From all reviewed studies, a total of 19 articles could be included evaluating the risk for bleeding in cardiac surgery related to DAPT or DOACs and 10 papers evaluating antithrombotic drug reversal or removal in the setting of cardiovascular surgery. Reported bleeding rates ranged between 18% and 41%. The variability of the reported data is remarkable. Idarucizumab is reported to provide optimal perioperative hemostasis in up to 93% of patients. It has been observed that andexanet alfa causes unresponsiveness to the anticoagulant effects of heparin. Antithrombotic removal by intraoperative hemoadsorption is found to be associated with a significant decrease in re-thoracotomy rate, overall procedure duration, administered transfusion volumes, chest-tube drainage, and length of hospitalization. Discussion: Bleeding complications in patients treated with DAPT or DOACs in cardiac surgery are high. New costly reversal agents are available but have not been sufficiently tested in the cardio-surgical setting so far. Interestingly, bleeding-related complications seem to be effectively reduced by applying innovative intraoperative hemoadsorption techniques. Expected results from the ongoing trials should provide better insights concerning the efficacy and safety of several potential solutions. Currently, the variability of reports and the deficit of high-quality studies in this specific setting represent the major limitation for the unbiased conclusion of this review

    Identification of Herbig Ae/Be Stars in the Small Magellanic Cloud

    Get PDF
    Protoplanetary disks orbiting intermediate-mass stars, Herbig Ae/Be stars, that have formed in a metal-poor environment may evolve differently than their Galactic cousins. A study of the planet-formation process in such an environment requires identification and characterization of a sample of candidates. We have observed several stars in the Small Magellanic Cloud, a nearby metal-poor dwarf galaxy, that have optical spectral properties of Herbig Ae/Be stars, including strong Hα emission, blue continuum excess, and spectral types ranging from early G to B. Infrared spectra of these sources from the Spitzer Space Telescope show strong excess emission indicating the presence of silicate dust, molecular and atomic gas, and polycyclic aromatic hydrocarbons. We present an analysis of the likelihood that these candidates are Herbig Ae/Be stars. This identification is the necessary first step to future investigations that will examine the role of metallicity in the evolution of protoplanetary disks

    withdrawn 2017 hrs ehra ecas aphrs solaece expert consensus statement on catheter and surgical ablation of atrial fibrillation

    Get PDF
    n/

    The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies

    Get PDF
    The German Centre for Cardiovascular Research (DZHK) is one of the German Centres for Health Research and aims to conduct early and guideline-relevant studies to develop new therapies and diagnostics that impact the lives of people with cardiovascular disease. Therefore, DZHK members designed a collaboratively organised and integrated research platform connecting all sites and partners. The overarching objectives of the research platform are the standardisation of prospective data and biological sample collections among all studies and the development of a sustainable centrally standardised storage in compliance with general legal regulations and the FAIR principles. The main elements of the DZHK infrastructure are web-based and central units for data management, LIMS, IDMS, and transfer office, embedded in a framework consisting of the DZHK Use and Access Policy, and the Ethics and Data Protection Concept. This framework is characterised by a modular design allowing a high standardisation across all studies. For studies that require even tighter criteria additional quality levels are defined. In addition, the Public Open Data strategy is an important focus of DZHK. The DZHK operates as one legal entity holding all rights of data and biological sample usage, according to the DZHK Use and Access Policy. All DZHK studies collect a basic set of data and biosamples, accompanied by specific clinical and imaging data and biobanking. The DZHK infrastructure was constructed by scientists with the focus on the needs of scientists conducting clinical studies. Through this, the DZHK enables the interdisciplinary and multiple use of data and biological samples by scientists inside and outside the DZHK. So far, 27 DZHK studies recruited well over 11,200 participants suffering from major cardiovascular disorders such as myocardial infarction or heart failure. Currently, data and samples of five DZHK studies of the DZHK Heart Bank can be applied for

    Okuläre Lues

    No full text

    Exploring cation siting in zeolite ZSM-5 by infrared spectroscopy, EXAFS and computer simulations

    No full text
    A new approach for retrieving information on cation siting in silicon-rich zeolites like ZSM-5 is presented. It is based on combined investigations using the cation sensitive methods, far-IR spectroscopy and EXAFS together with computer simulations. This combination proved to be successful for alkali and even for alkaline earth ions. It was possible to obtain cation locations for Cs+ as well as for Ba2+ ions in ZSM-5. In this context the series of far-infrared spectra of alkali exchanged ZSM-5 is shown for the first time
    • …
    corecore